Pfizer (PFE)

$25.26 1.01 (3.84%)

16:10 EDT PFE Stock Quote Delayed 30 Minutes

The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 24, 2024

Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco.

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years

The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback

Volume:

Previous Close -

Market Cap 141.62B

PE Ratio 68.27

EPS 0.37

Volume (Avg. Vol.) 47.09M

Day's Range $25.25 - $26.43

52-Week Range $25.23 - $40.37

Dividend & Yield $1.64 (6.49%)

PFE Stock Predictions, Articles, and Pfizer News

From InvestorPlace
From the Web

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape

By Josh Enomoto, InvestorPlace Contributor Apr 10, 2024

With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access…

3 Dirt-Cheap Stocks That Could Make You Filthy Rich

By Muslim Farooque, InvestorPlace Contributor Apr 9, 2024

Cheap stocks offer a silver lining as the Fed takes a cautious stance, presenting opportunities for savvy investors.

The 3 Most Undervalued Healthcare Stocks to Buy in April 2024

By Joel Baglole, InvestorPlace Contributor Apr 8, 2024

Health insurers, pharmaceutical companies and medical device manufacturers have all been knocked lower as an aging population drives up medical costs and companies struggle to maintain their profit margins.

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

By Joey Frenette, InvestorPlace Contributor Apr 5, 2024

The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.

The Comeback Kids: 7 Stocks Ready to Rise from the Ashes

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 4, 2024

Discover seven resilient comeback stocks thriving across diverse sectors, from pharma to tech, poised for growth amid economic flux.

Unbeatable Blue Chips: 7 Must-Own Stocks for Every Portfolio

By Alex Sirois, InvestorPlace Contributor Apr 1, 2024

Blue chip stocks are excellent wealth builders and a must own for every portfolio of every size and investment style.

Blue-Chip Bulldozers: 7 Stock Giants to Plow Through a Wall of Worries

By Josh Enomoto, InvestorPlace Contributor Apr 1, 2024

It’s an interesting time in the market, which may bode well for conservative ideas found among blue-chip stocks. Underlying this category are some of the…

Spring Cleaning Alert: 7 Dreadful Stocks to Ditch Now

By Louis Navellier and the InvestorPlace Research Staff Mar 29, 2024

This time of year brings many tasks, holiday shopping and making Easter eggs, mowing the grass for perhaps the first time all year, and giving…

7 Dividend Stocks to Secure Your Financial Freedom by 2026

By Yiannis Zourmpanos, InvestorPlace Contributor Mar 29, 2024

Explore seven dividend stocks for financial freedom in banking, insurance, construction, pharmaceuticals, and telecommunications.

The 2025 Double: 3 Stocks Poised to Deliver 100% Gains in Just 12 Months

By Alex Sirois, InvestorPlace Contributor Mar 27, 2024

Let's review what Wall Street analysts believe are potentially the stocks to double over the next 12 months.

Harnessing AI for Drug Discovery: Top 3 Stocks to Watch

By Joey Frenette, InvestorPlace Contributor Mar 26, 2024

As biotech innovators look to AI to smoothen out the drug discovery process, the leaders in the scene could stand to benefit greatly.

Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating

By Rich Duprey, InvestorPlace Contributor Mar 25, 2024

Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight.

7 Stocks That Will Make Your Friends Green With Envy

By Matthew Farley, InvestorPlace Contributor Mar 23, 2024

Discover stocks set to dazzle the market with innovative business models and disruptive technologies. Dive in for potential outperformance.

7 High-Value Stocks With Massive Wealth-Building Potential

By Yiannis Zourmpanos, InvestorPlace Contributor Mar 22, 2024

Explore high-value stocks shaping the future across semiconductors, digital payments, AI, and healthcare for savvy investors.

3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50

By Alex Sirois, InvestorPlace Contributor Mar 19, 2024

These dividend stocks selling for under $50 with yields of 5% or more offer a lot to investors at any time making these strong buys.

7 Dangerous Dividend Stocks to Avoid at All Costs: March 2024

By Louis Navellier and the InvestorPlace Research Staff Mar 18, 2024

Lurking in the weeds like a tiger ready to strike, these dangerous dividend stocks are set to wreak havoc on any investment portfolio.

3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise

By Matthew Farley, InvestorPlace Contributor Mar 15, 2024

Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities.

The 3 Most Undervalued Healthcare Stocks to Buy in March 2024

By Muslim Farooque, InvestorPlace Contributor Mar 14, 2024

Wager on these promising undervalued healthcare stocks, catering to investors aiming to leverage growth within the dynamic healthcare space

Want $2K Per Month in Retirement? Buy These 3 Dividend Stocks Now.

By Alex Sirois, InvestorPlace Contributor Mar 14, 2024

Investors wanting to enjoy some passive income during retirement should invest in these 3 dividend stocks.

The 3 Most Undervalued Biotech Stocks to Buy in March 2024

By Chandler Capital, InvestorPlace Contributor Mar 13, 2024

These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March.

Pfizer (PFE)

The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years

The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Pfizer (PFE)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PFE Stock Predictions, Articles, and Pfizer News

Subscriber Sign in